When do you consider extended courses of oseltamivir in immunocompromised patients?

For immunocompromised individuals with severe influenza, I recommend a 10-day course of oseltamivir based on AST ID-COP guidelines (Manuel et al., PMID 30817023). Practically speaking, this is any immunocompromised patient who is hospitalized due to influenza.